Join us at the ASA in San Francisco from 14-17 October at Booth 2256. Experience quantitative neuromuscular block monitoring with the new STIMPOD NMS450X+. #ANES23#eliminateRNB2025#XavantTechnology
Just dropped MUST-WATCH video on Sugammadex vs Neostigmine!
📊 Get data-driven insights
🛡️ Elevate patient safety
🎥 Watch & join the conversation! https://t.co/ILbjvcRBT5
Want more like this? Hit that follow button! #Sugammadex#Neostigmine#patientsafety#eliminateRNB2025
Dr. Hugo Carvalho reveals a positive trend in reducing residual neuromuscular block in new meta-analysis. 🤝 Sponsored by #XavantTechnology with a mission to #eliminateRNB2025. Let's make it a reality!
📷 Watch Now https://t.co/li6gDOKHVT
Follow us for more insights!
New @ESAIC_org Guidelines Alert in #Anesthesiology & #IntensiveCare! Rethink using Neostigmine: now advised only when TOF count is 4 AND TOF ratio > 0.2
Research shows high-risk if TOF < 0.2
🎥Watch the video extract for more https://t.co/EqvELPXHT4
#stimpod#eliminateRNB2025
Our course on Residual Neuromuscular Block (RNB) is now FREE on @Xpeer5 Medical Education! Dive into NMT monitoring complexities, neuromuscular blockade pitfalls & enhance patient safety in anaesthesiology. Access & earn 1 ECMEC credit
https://t.co/xKB5n3UnKS
#eliminateRNB2025
Our new video dives deep into the risks of facial nerve monitoring, revealing insights on neuromuscular blocking agents & residual paralysis. Be informed and join the global effort to #eliminateRNB2025. Perfect for medical pros & students! #patientsafety#medicaleducation
Exploring the best practices in anesthesia care. A thought-provoking study from Dr Kotake uncovers a 4% incidence of residual paralysis with Sugammadex. Join Dr. Cammu in understanding the significance of neuromuscular monitoring. #Anesthesia#PatientSafety#eliminateRNB2025
Ever wondered why some muscles are more resistant to neuromuscular blocking agents than others? Unlock the mysteries of muscle sensitivity with our latest video! Great for medical pros, students, or the curious mind. Don't miss out👇
https://t.co/xYzelFUVa4
#eliminateRNB2025
Simulated TOF ratios based on published PK/PD models do not accurately predict real intraoperative TOF ratio dynamics. Great study, important conclusion.
https://t.co/ceOvsEJuI9
👀 this video for further insights into neuromuscular blockade monitoring👇
https://t.co/i7pzQnjhpc
Think clinical signs alone determine the right moment for extubation? Dive into our latest video as we bust this common myth and navigate the complexities of extubation readiness.
#patientsafety#behindthemask#eliminateRNB2025#stimpod
A new laboratory-built #mechanomyograph and an archival mechanomyograph obtained similar train-of-four ratio measurements, reassuring comparability of past and future studies performed with modern mechanomyography systems. Read more: https://t.co/OGMUPjYhD3
If you like these insights, follow us @Xavant_Tech.
Click the link below to access the full webinar on our Xavant YouTube channel 👇
https://t.co/asnlS8g7o0
Pitfall #4
“If I use a reversal agent, I do not have to monitor”
Unmonitored antagonization proven to be very ineffective. New guidelines requires TOF Ratio’s of 20%-40% for optimal reversal using #Neostigmine, and residual block is still possible even when using #Sugammadex